Riskpilot← Back to searchSign inGet full accessGANDDAL HELSEHUS AS
ASActiveOrg 976728831Olabakken 5, 4322 SandnesRental and operating of own or leased real estate · NACE 6820Est. 19960 employees
Revenue 2025
NOK 3,2M
+2% vs 2024
EBITDA margin
50.8%
-8% vs 2024
Equity ratio
82.5%
Financial strength
Net profit 2025
NOK 809K
-29% vs 2024
| Revenue | NOK 3,2M | +2% |
| EBITDA | NOK 1,6M | -8% |
| Net profit | NOK 809K | -29% |
| Total assets | NOK 10,6M | +18% |
| Equity | NOK 8,8M | +10% |
| Employees | 0 | — |
Legal name
GANDDAL HELSEHUS AS
Org number
976728831
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
27. august 1996
Share capital
—
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Address
Olabakken 5, 4322 Sandnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 746 | 3 008 | 3 238 | 3 174 | 3 224 |
| Staff expenses | −8 | −0 | −0 | −32 | −10 |
| EBITDA | 1 674 | 1 726 | 2 064 | 1 776 | 1 637 |
| Depreciation & amort. | −186 | −285 | −302 | −302 | −513 |
| EBIT | 1 488 | 1 441 | 1 762 | 1 474 | 1 124 |
| Net financials | −47 | −41 | −25 | −15 | −88 |
| Profit before tax | 1 441 | 1 400 | 1 737 | 1 459 | 1 037 |
| Tax | 317 | 308 | 382 | 321 | 228 |
| Net profit | 1 124 | 1 092 | 1 355 | 1 138 | 809 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 224 | 8 900 | 9 323 | 8 991 | 10 641 |
| Equity | 6 684 | 6 676 | 6 831 | 7 969 | 8 777 |
| Long-term debt | 1 595 | 1 046 | 598 | 476 | 315 |
| Short-term debt | 945 | 1 177 | 1 894 | 546 | 1 549 |
| Total debt | 2 540 | 2 223 | 2 492 | 1 022 | 1 864 |
EBITDA margin
50.8%
This company
15.8%
Market median
+222% vs market
20212025
Equity ratio
82.5%
This company
38.2%
Market median
+116% vs market
20212025
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
20212025
Net profit margin
25.1%
This company
8.1%
Market median
+210% vs market
20212025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OM Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2010 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GANDDAL HELSEHUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Moi | Chief Executive Officer | 0 companies |
| Svein Arne Sirevåg | Chairman | 0 companies |
| Audun Veggeland | Board of Directors | 0 companies |